Discovery of small-molecule modulator of heterotrimeric G i-protein by integrated phenotypic profiling and chemical proteomics

Biosci Biotechnol Biochem. 2020 Dec;84(12):2484-2490. doi: 10.1080/09168451.2020.1812375. Epub 2020 Aug 31.

Abstract

Discovery of small-molecule inducers of unique phenotypic changes combined with subsequent target identification often provides new insights into cellular functions. Here, we applied integrated profiling based on cellular morphological and proteomic changes to compound screening. We identified an indane derivative, NPD9055, which is mechanistically distinct from reference compounds with known modes of action. Employing a chemical proteomics approach, we then showed that NPD9055 binds subunits of heterotrimeric G-protein Gi. An in vitro [35S]GTPγS-binding assay revealed that NPD9055 inhibited GDP/GTP exchange on a Gαi subunit induced by a G-protein-coupled receptor agonist, but not on another G-protein from the Gαs family. In intact HeLa cells, NPD9055 induced an increase in intracellular Ca2+ levels and ERK/MAPK phosphorylation, both of which are regulated by Gβγ, following its dissociation from Gαi. Our observations suggest that NPD9055 targets Gαi and thus regulates Gβγ-dependent cellular processes, most likely by causing the dissociation of Gβγ from Gαi.

Keywords: Phenotypic screening; chemical proteomics; heterotrimeric G-protein; profiling; target identification.

MeSH terms

  • Cell Line, Tumor
  • Drug Discovery*
  • Heterotrimeric GTP-Binding Proteins / metabolism*
  • Humans
  • Phenotype*
  • Proteomics*
  • Small Molecule Libraries / pharmacology*

Substances

  • Small Molecule Libraries
  • Heterotrimeric GTP-Binding Proteins